Samsung
Gene Therapy Firm Latus Launches With $54M Series A Financing
The company will use the funds to advance gene therapies for CNS disorders such as neuronal ceroid lipofuscinosis type 2 and Huntington's disease.
In Brief This Week: Bristol Myers Squibb, Kinnate Biopharma, Biocept, Nexcella, DermTech
News items for the week of Sept. 18, 2023.